natgillin/translations-raw huggingface dataset:
BROADLINE spot-on solution
otopina za nakapavanje
BROADLINE spot-on solution for cats < 2.5 kg BROADLINE spot-on solution for cats 2.5-7.5 kg
BROADLINE otopina za nakapavanje za mačke < 2,5 kg BROADLINE otopina za nakapavanje za mačke 2,5-7,5 kg
BROADLINE spot-on solution for cats < 2.5 kg BROADLINE spot-on solution for cats 2.5–7.5 kg
BROADLINE otopina za nakapavanje za mačke < 2,5 kg BROADLINE otopina za nakapavanje za mačke 2,5 do 7,5 kg
BROADLINE spot-on solution for cats < 2.5 kg BROADLINE spot-on solution for cats 2.5–7.5 kg
BROADLINE spot on otopina za mačke < 2,5 kg BROADLINE spot on otopina za mačke 2,5 kg -7,5 kg
BROADLINE spot-on solution for cats <2.5 kg BROADLINE spot-on solution for cats 2.5–7.5 kg
BROADLINE spot-on otopina za mačke < 2,5 kg BROADLINE spot-on otopina za mačke 2,5 do 7,5 kg
Broadline treated cats were compared to cats treated with a spot-on product containing the worm medicines emodepside and praziquantel.
Mačke tretirane VMP-om Broadline uspoređene su s mačkama tretiranima spot-on VMP-om koji sadrži VMP-ove protiv crva emodepzid i prazikvantel.
Broadline was more than 90% effective in reducing lungworm larvae at 28 days after treatment and all treated cats showing respiratory signs (such as wheezing, persistent coughing and a runny nose) were clinically cured.
Djelotvornost VMP-a Broadline iznosi više od 90 % u smanjenju ličiki plućnog crva 28 dana nakon liječenja i sve liječene mačke koje su pokazale su respiratorne znakove (kao što je hripanje, uporan kašalj i curenje iz nosa) bile su klinički izliječene.
Brochure for male patients
Knjižice za muške bolesnike.
Brochure for women patients of childbearing potential and their partners
knjižice za bolesnice u generativnoj dobi i njihove partnere
Brochure for women patients of childbearing potential and their partners
Knjižice za bolesnice u reproduktivnoj dobi i njihove partnere.
Brochure for women patients who are not of childbearing potential
Knjižice za bolesnice koje nisu u reproduktivnoj dobi.
Brochure for women patients with childbearing potential
Knjižica za bolesnice u generativnoj dobi
Brochure on breakthrough pain
Brošure o probijajućem bolu
Broken bones have been reported commonly (up to 1 in 10 people) in women patients taking pioglitazone.
Prijelomi kostiju često (u do 1 na 10 ljudi) su zabilježeni u žena koje su uzimale pioglitazon.
Broken bones usually occur at the hip, spine, or wrist and can lead not only to pain but also to considerable problems like stooped posture (‘dowager’s hump’) and loss of mobility.
Najčešća mjesta prijeloma su kuk, kralježnica ili ručni zglob, a uz bol se kao posljedica mogu pojaviti i teži problemi kao što su pogrbljeno držanje (grbavost) i gubitak pokretljivosti.
Broken skin and areas which are bruised or covered by a rash should be avoided.
Ozlijeđenu kožu i područja s masnicama ili pokrivena osipom valja izbjegavati.
Bromelain may enhance the hypotensive effect of ACE inhibitors, causing larger decreases in blood pressure than expected.
Bromelain može pojačati hipotenzivni učinak ACE inhibitora uzrokujući veće sniženje arterijskog tlaka od očekivanog.
bromocriptine
bromokriptinom
bronchial asthma
bronhalnu astmu
Bronchial haemorrhage
bronhalno krvarenje
Bronchial spasm, Bronchitis, Epistaxis, Pneumonitis (see section 4.3), Pneumonia, Pulmonary congestion, Rhinitis, Sinusitis, Sore throat
bronhospazam, bronhitis, epistaksa, pneumonitis (vidjeti dio 4.3), pneumonija, plućna kongestija, rinitis, sinusitis, grlobolja
Bronchial spasm, Cough, Pneumonia, Pneumonitis (see section 4.3), Sore throat
bronhospazam, kašalj, upala pluća, pneumonitis (vidjeti dio 4.3), grlobolja
Bronchiolitis (inflammation of small bronchi with breathing difficulties and wheeze in the chest, associated with cough and fever),
Bronhiolitis (upala malih bronhija s otežanim disanjem i piskanjem u prsima, popraćen kašljem i vrućicom),
Bronchiolitis, Candida nappy rash, Candidiasis, Cellulitis, Infectious croup, Viral gastroenteritis, Hand-foot-mouth disease, Influenza, Pseudocroup, Respiratory infection, Skin infection, Tonsillitis, Varicella+ ‡, Viral conjunctivitis
bronhiolitis, pelenski osip prouzročen kandidom, kandidijaza, celulitis, infektivni krup, virusni gastroenteritis, bolest šake, stopala i usta, influenca, pseudokrup, respiratorna infekcija, infekcija kože, tonzilitis, varičela+ ‡, virusni konjunktivitis
Bronchitis
bronhitis
Bronchitis (inflammation of the airways)
bronhitis (upala dišnih putova)
Bronchitis (inflammation of the bronchi),
Bronhitis (upala bronhija),
Bronchitis (lung infection)
Bronhitis (infekcija pluća)
Bronchitis Bronchiolitis
učestalost
Bronchitis Bronchopneumonia Dysphonia Hyperventilation Sputum Discoloured Throat irritation Pharyngitis
Bronhitis Bronhopneumonija Disfonija Hiperventilacija Promjena boje sputuma Nadraženost grla Faringitis
Bronchitis viral
Virusni bronhitis
Bronchitis*, cellulitis*, herpes simplex, influenza, oral fungal infection, sinusitis
bronhitis*, celulitis*, herpes simplex, gripa, gljivična infekcija usne šupljine, sinusitis
Bronchitis,
putova,
Bronchitis, apnoea2 [see section 4.4 for apnoea in very preterm infants (≤ 28 weeks of gestation)]
bronhitis, apneja2 [vidjeti dio 4.4 za apneju u znatno prijevremeno rođene djece (≤ 28 tjedana gestacije)]
Bronchitis, candidiasis, cellulitis, herpes zoster, meningitis, nail infection, oral fungal infection, oral herpes, pneumonia, salmonella gastroenteritis, septic shock
Bronhitis, kandidijaza, celulitis, herpes zoster, meningitis, infekcija noktiju, gljivična infekcija usne šupljine, herpes usne šupljine, upala pluća, gastroenteritis uzrokovan salmonelom, septički šok
Bronchitis, cough, wheezing
Bronhitis, kašalj, piskanje
Bronchitis, Gastroenteritis, Upper respiratory tract infection, Influenza, Sinusitis, Pharyngitis
bronhitis, gastroenteritis, infekcija gornjeg dišnog sustava, gripa, sinusitis, faringitis
Bronchitis, Herpes simplex, Nasopharyngitis, Upper respiratory tract infections, Sinusitis
bronhitis, herpes simplex, nazofaringitis, infekcije gornjih dišnih putova, sinusitis
Bronchitis, nasopharyngitis
bronhitis, nazofaringitis
Bronchitis, sinusitis, gastroenteritis, tinea pedis
bronhitis, sinusitis, gastroenteritis, tinea pedis
Bronchitis, upper respiratory infection, oral candidiasis, herpes simplex, fungal, viral and bacterial infections
bronhitis, infekcija gornjeg dišnog sustava, oralna kandidijaza, herpes simpleks, gljivične, virusne i bakterijske infekcije
bronchitis, upper respiratory tract infection
bronhitis, infekcija gornjih dišnih putova
bronchitis, upper respiratory tract infection, sinusitis, urinary tract
bronhitis, infekcija gornjih dišnih puteva, sinusitis, infekcija urinarnog trakta, influenca
bronchitis, upper respiratory tract infection, sinusitis, urinary tract infection, influenza
bronhitis, infekcija gornjih dišnih puteva, sinusitis,
bronchitis, upper respiratory tract infection, sinusitis, urinary tract infection, influenza
bronhitis, infekcija gornjih dišnih puteva, sinusitis, infekcija urinarnog trakta, influenca
Bronchitol 40 mg capsules are presented in double aluminium blisters in cartons containing 10 or 280 capsules for initial dose and treatment use respectively.
Kapsule lijeka Bronchitol od 40 mg isporučuju se u dvostrukim aluminijskim blisterima u kutijama s 10 kapsula za početno doziranje ili 280 kapsula za terapijsku primjenu.
Bronchitol 40 mg inhalation powder, hard capsules contain a white or almost white powder filled into clear, colourless, hard, capsules with “PXS 40 mg” imprinted on them.
Bronchitol prašak za inhalaciju od 40 mg, tvrde kapsule sadrže bijeli ili gotovo bijeli prašak unutar prozirne, bezbojne, tvrde kapsule s oznakom “PXS 40 mg”.
Bronchitol 40 mg, inhalation powder, hard capsules Mannitol
Bronchitol 40 mg prašak inhalata, tvrde kapsule manitol
Bronchitol 40 mg, inhalation powder, hard capsules Mannitol
Bronchitol 40 mg, prašak inhalata, tvrde kapsule manitol
Bronchitol capsules can only be used with the inhaler provided in the pack.
Bronchitol kapsule smiju se rabiti isključivo uz pomoć inhalatora priloženog u pakovanju.
Bronchitol capsules must always be stored in the blister to protect from moisture and only removed immediately before use.
Kapsule lijeka Bronchitol moraju se uvijek čuvati u blisteru radi zaštite od vlage te se smiju izvaditi iz blistera isključivo netom prije uporabe.
Bronchitol contains a medicine called mannitol which is a mucolytic agent.
Bronchitol sadrži lijek manitol koji je mukolitički agens.
Bronchitol has no or negligible influence on the ability to drive and use machines.
Bronchitol ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada na strojevima.
Bronchitol has not specifically been studied in patients with impaired renal and hepatic function.
Bronchitol nije posebno ispitan u pacijenata s oštećenjem funkcije bubrega ili jetre.
Bronchitol is a powder for inhalation that is filled into capsules.
Bronchitol je prašak za inhalaciju smješten u kapsule.
Bronchitol is administered by the oral inhalation route using the inhaler provided in the pack.
Bronchitol se primjenjuje oralnom inhalacijom pomoću inhalatora isporučenog u paketu.
Bronchitol is breathed in (inhaled) as a powder from the capsule using the inhaler supplied in the pack.
Bronchitol se udiše (inhalira) u obliku praška iz kapsule uz pomoć inhalatora isporučenog u paketu.
Bronchitol is not likely to affect your ability to drive or use any tools or machines.
Bronchitol ne utječe na sposobnost upravljanja vozilima i rada na strojevima.
Bronchitol must not be used by children and adolescents under the age of 18.
Bronchitol ne smiju upotrebljavati djeca i adolescenti mlađi od 18 godina.
bronchoconstriction and anaphylaxis (a severe, whole-body allergic reaction), constant cough,
bronhokonstrikcija i anafilaksija (teška alergijska reakcija cijelog organizma), uporan kašalj,
Bronchodilator therapy, such as salbutamol
Terapija bronhodilatatorima, kao što je salbutamol
bronchodilators (beta-2 agonists) which are used to treat asthma
bronhodilatatore (beta-2 agoniste), lijekove za liječenje astme
bronchodilators (beta-2 agonists) which are used to treat asthma ramipril, lisinopril and enalapril (ACE inhibitors) used to treat high blood pressure
bronhodilatatori (beta-2 agonisti), koji se koriste za liječenje astme ramipril, lizinopril i enalpril (ACE inhibitori), koriste se za liječenje povišenog krvnog tlaka
bronchodilators (beta-2 agonists) which are used to treat asthma.
bronhodilatatore (beta-2 agoniste) koji se primjenjuju za liječenje astme.
bronchodilators (β-sympathomimetics) for the treatment of bronchial asthma. iodinated contrast agents (which you may receive while having X-ray) or alcohol-containing medicines, see 'Warnings and precautions'.
bronhodilatatori (β-simpatomimetici) za liječenje bronhalne astme. jodirana kontrastna sredstva (koja možete primiti tijekom rendgenske pretrage) ili lijekovi koji sadrže alkohol, vidjeti „Upozorenja i mjere opreza“.
bronchodilators, used to treat asthma and other lung-related problems:
bronhodilatatore, primjenjuju se za liječenje astme i drugih tegoba s plućima:
Bronchodilators;
Bronhodilatatori;
bronchospasm (0.2% vs 0%), exertional dyspnoea (0.5% vs 0.5%)
bronhospazam (0,2% prema 0%), dispneja pri naporu (0,5% prema 0,5%)
Bronchospasm (breathing difficulties),
Bronhospazam (otežano disanje),
bronchospasm (predominantly in patients with pre-existing bronchospastic disease)
bronhospazam (pretežno u bolesnika s već postojećom bronhospastičnom bolešću)
bronchospasm (predominantly in patients with pre-existing bronchospastic disease), asthma
bronhospazam (pretežno u bolesnika s već postojećom bronhospastičnom bolešću), astma
Bronchospasm (predominantly in patients with pre-existing bronchospastic disease).
brohnospazam (najčešće kod bolesnika s od ranije poznatom bronhospastičnom bolešću).
Bronchospasm (sudden constriction of the muscles in the walls of the small airways) and wheezing (see also section 2 “Warnings and precautions”)
Bronhospazam (iznenadno stezanje mišića u stijenkama malih dišnih putova) i piskanje pri disanju (pogledajte također dio 2 "Upozorenja i mjere opreza").
Bronchospasm (tightening of the muscles in the airways which causes wheezing and shortness of breath).
Bronhospazam (stezanje mišića u dišnim putevima koje uzrokuje zviždanje i nedostatak zraka).
Bronchospasm (tightening of the muscles in the airways which causes wheezing and shortness of breath).
Bronhospazam (stezanje mišića u dišnim putevima koje uzrokuje zviždanje u plućima i nedostatak zraka).
bronchospasm (wheezing or coughing), hives*.
bronhospazam (piskanje pri disanju ili kašalj), koprivnjača
Bronchospasm can occur with inhalation of medicinal products and has been reported with the use of nebulised tobramycin.
Tijekom inhalacije lijekova može nastupiti bronhospazam a zabilježen je i prilikom primjene atomiziranog tobramicina.
Bronchospasm Cough Hyperventilation Hypoxia Laryngeal oedema
bronhospazam kašalj hiperventilacija hipoksija
Bronchospasm may develop particularly in patients with asthma.
Kod bolesnika s astmom može se razviti bronhospazam.
Bronchospasm Nasal dryness
Bronhospazam Suhoća nosa
Bronchospasm*
Bronhospazam
Bronchospasm* (see section 4.4) / Wheezing
bronhospazam* (vidjeti dio 4.4) / piskanje
Bronchospasm*, hypoxia*, dyspnoea*, chest discomfort*, pharyngolaryngeal pain*, cough*, nasal congestion*
bronhospazam*, hipoksija*, dispneja*, nelagoda u prsnom košu*, faringolaringealna bol*, kašalj*, kongestija nosa
bronchospasm,
bronhospazam,
Bronchospasm, including paradoxical4
Bronhospazam, uključujući paradoksalni4
bronchospasm, pharyngolaryngeal pain, rhinnorhoea, tachypnoea, upper respiratory tract congestion
bronhospazam, faringolaringealna bol, rinoreja, tahipneja, kongestija gornjeg dišnog sustava
Bronchospasm, pulmonary oedema
bronhospazam, plućni edem
Bronchospasm, Respiratory arrest
bronhospazam, respiratorni zastoj
Bronchospasm-like symptoms
simptomi slični bronhospazmu
bronchospasm1, chest discomfort, rhinorrhoea, haemoptysis1
bronhospazam1, osjećaj nelagode u prsištu, rinoreja, hemoptiza1
Bronchospasm2
bronhospazam2
Bronchospasm4,
bronhospazam4,
Bronchospasm4,
Vrlo često
Bronchospasm; Tachypnoea; Haemoptysis; Epistaxis
bronhospazam; tahipneja; hemoptiza; epistaksa
Brown
međa
Brown glass bottles (Hydrolytic Class III) containing either 50 ml, 100 ml or 10 x 50 ml solution.
Smeđe staklene bočice (hidrolitička skupina III) koje sadržavaju 50 ml, 100 ml ili 10 x 50 ml otopine.
Brown glass bottles (Hydrolytic Class III) containing either 50, 100 ml or 500ml (10 x 50 ml) solution.
Smeđe staklene boce (hidrolitička skupina III) koje sadržavaju 50 ml, 100 ml ili 500ml (10 x 50 ml) otopine.
Brown spots or patches on the face
međe pjege ili mrlje na licu
Brown, bone-shaped tablets with a score mark on each side.
Smeđe tablete u obliku kosti s razdjelnom linijom na svakoj strani .
Brown, diamond shaped 20 mg film-coated tablet of 10 mm length with “APR” engraved on one side and “20” on the opposite side.
Smeđa, filmom obložena tableta od 20 mg u obliku romba, duljine 10 mm, s utisnutom oznakom “APR” na jednoj strani te “20” na drugoj strani.
Brown-yellow, ovaloid, biconvex tablets with bevelled edge, debossed “NVR” on one side and “VFL” on the other side.
Smeđe-žute, ovalne, bikonveksne tablete s kosim rubovima, s utisnutom oznakom „NVR“ na jednoj strani i „VFL“ na drugoj strani.
Brown-yellow, ovaloid, biconvex tablets with bevelled edge, debossed “NVR” on one side and “VHL” on the other side.
Smeđe-žute, ovalne, bikonveksne tablete s kosim rubovima, s utisnutom oznakom „NVR“ na jednoj strani i „VHL“ na drugoj strani.
Brownish or greyish red, elongated-ellipse shaped, unscored film-coated tablets marked with ‘LCE 150’ on one side.
Smećkaste ili sivkasto-crvene, izdužene filmom obložene tablete u obliku elipse, bez ureza, s oznakom "LCE 150" na jednoj strani.
Brownish or greyish red, oval, unscored film-coated tablets marked with ‘LCE 100’ on one side.
Smećkasto ili sivkasto-crvene, ovalne filmom obložene tablete, bez ureza, s oznakom "LCE 100" na jednoj strani.
Brownish or greyish red, round, convex, unscored film-coated tablets marked with ‘LCE 50’ on one side.
Smećkasto ili sivkasto-crvene, okrugle, konveksne filmom obložene tablete, bez ureza, s oznakom "LCE 50" na jednoj strani.
Brownish orange, oval shaped, biconvex, film-coated tablets, debossed on one side with ‘IM’ and ‘T2’ on either side of breakline and plain on the other side.
Smećkastonarančaste, ovalne, bikonveksne filmom obložene tablete s utisnutom oznakom „IM“ na jednoj strani razdjelne crte i „T2“ na drugoj strani razdjelne crte te bez oznaka na drugoj strani tablete.
Brownish orange, round, biconvex, film-coated tablets, debossed on one side with ‘IM’ and ‘T1’ on either side of breakline and plain on the other side.
Smećkastonarančaste, okrugle, bikonveksne filmom obložene tabletes utisnutom oznakom „IM“na jednoj strani razdjelne crte i „T1“na drugoj strani razdjelne crte te bez oznaka na drugoj strani tablete.
bruise more easily
lakše dobivati modrice
Bruises
modrica
bruises due to a low platelet count
modrice zbog niskog broja trombocita
Bruises, falls and injuries
nastanak modrica, padovi i ozljede
Bruising
modrice
Bruising
nastanak modrica
bruising
tvaranje modrica
Bruising
Često
bruising (contusion);
tvaranje modrica (kod ozljeda);
bruising (ecchymosis)
modrice (ekhimoza)
Bruising (haematoma and contusion)
Modrice (hematomi i ozljede)
bruising (haematoma) where the injection is given stomach and digestion problems such as diarrhoea, vomiting and nausea.
modrica (hematom) na mjestu davanja injekcije problemi sa želucem i probavom poput proljeva, povraćanja i mučnine.
bruising (including purpura),
tvaranje modrica (uključujući purpuru),
Bruising and fractures.
modrice i prijelomi
bruising and swelling in your stomach, your bowel, into the rectum
nastanak modrica i oticanje u želucu, crijevima, završnom dijelu debelog crijeva
bruising and swelling vaginal bleeding
nastanak modrica i oticanje vaginalno krvarenje
bruising at the injection site
tvaranje modrica na mjestu injiciranja
Bruising at the injection site.
Modrica na mjestu primjene.
Bruising events were more frequently reported in patients taking Jakavi compared with the reference treatments (21.3% versus 11.6%).
Modrice su bile češće prijavljivane u bolesnika koji su uzimali Jakavi u usporedbi s referentnim terapijama (21,3% u odnosu na 11,6%).
bruising gastro-intestinal bleeding (e.g. bleeding from the stomach or bowel)
tvaranje modrica gastrointestinalno krvarenje (krvarenje iz želuca ili crijeva)
bruising gastro-intestinal bleeding (e.g. bleeding from the stomach or bowel)
tvaranje modrica gastrointestinalno krvarenje (npr. krvarenje iz želuca ili crijeva)
Bruising of the skin at the injection site, fever and nausea
Stvaranje modrica na koži na mjestu injekcije, vrućica i mučnina
Bruising of the skin.
Modrice na koži.
Bruising or bleeding at injection site, soreness or swelling at injection site, build up of fat below the surface of the skin at injection site, swelling of the extremities, weakness, fever.
modrica ili krvarenje na mjestu primjene injekcije, bolnost ili oteknuće na mjestu primjene injekcije, nakupljanje masnog tkiva ispod površine kože na mjestu injekcije, oticanje udova, slabost, vrućica
Bruising or bleeding more easily than normal.
tvaranje modrica ili krvarenje više nego obično
Bruising or bleeding under the skin
modrice ili potkožno krvarenje
Bruising or pain at the injection site
modrica ili bol na mjestu primjene injekcije
bruising or swelling (oedema)
modrice ili oticanje (edemi)
bruising or swelling of the penis and pain in the penis a small collection of blood under the skin at the injection site
modrice ili oticanje penisa i bol u penisu mala nakupina krvi pod kožom na mjestu injekcije
Bruising was reported in similar frequencies in Jakavi and BAT arms (10.9% versus 8.1%).
Stvaranje modrica bilo je zabilježeno sličnom učestalošću u skupinama koje su primale Jakavi ili NDT (10,9% naspram 8,1%).
bruising,
Rijetko
bruising, hair loss, changes to skin colour, increased sweating, dry skin, or other skin problems;
nastanak modrica, gubitak kose, promjene boje kože, pojačano znojenje, suha koža ili druge tegobe s kožom;
Bruising, hot flush or nosebleed, warm, red skin (flushing)
modrice, napadaji vrućine ili krvarenje iz nosa, crvenilo kože (crvenilo praćeno osjećajem užarenosti)
bruising, shaking
tvaranje modrica, drhtanje
Bruising.
modrice
Bruising.
modrice.
bruising;
tvaranje modrica,
Brusing of the skin at the injection site
Modrice na koži na mjestu injekcije
Brusing of the skin at the injection site, fever and nausea, generally feeling unwell and shivering.
Modrice na koži na mjestu injiciranja, vrućica i mučnina, općenito loše osjećanje i tresavica.
Bruxism Disorientation Apathy
bruksizam dezorijentacija apatija
BSA (m2)
TJELESNA POVRŠINA (m2)
BSA (m2) =  (Height (cm) X Weight (kg) / 3600)
PT (m2) =  (visina (cm) X težina (kg) / 3600)
BSA (m2) =  (Height (cm) X Weight (kg) / 3600)
PT (m²) = √ (Visina (cm) X Težina (kg) / 3600)
BSA (m2) X 70 mg/m2 = Loading Dose
PT (m2) × 70 mg/m2 = udarna doza
BSA = (W0.425 x H0.725) x 0.007184
PT = (T0,425 x V0,725) x 0,007184
BSA = 1.30 - 1.49 m2
BSA = 1,30 – 1,49 m2
BSA = 1.30 - 1.62 m2
BSA = 1,30 – 1,62 m2
BSA = 1.30 - 1.66 m2
BSA = 1,30 – 1,66 m2
BSA = 1.50 - 1.69 m2
BSA = 1,50 – 1,69 m2
BSA = 1.63 - 1.87 m2
BSA = 1,63 – 1,87 m2
BSA = 1.67 - 2.16 m2
BSA = 1,67 – 2,16 m2
BSA = 1.70 - 1.89 m2
BSA = 1,70 – 1,89 m2
BSA = 1.88 - 2.12 m2
BSA = 1,88 – 2,12 m2
BSA = 1.90 - 2.09 m2
BSA = 1,90 – 2,09 m2
BSA = 2.10 - 2.29 m2
BSA = 2,10 – 2,29 m2
BSA range (m2)
BSA raspon (m2)
BSA Range (m2)
Površina tijela raspon (m2)
BSA subject (m2) x 1.73
PT bolesnika (m2)
BSA- normalized clearance of bortezomib in paediatric patients was similar to that observed in adults.
BSA-normalizirani klirens bortezomiba u pedijatrijskih bolesnika bio je sličan onom zabilježenom u odraslih.
BSA-normalized clearance and half-life were similar across the age range and consistent with that determined in healthy adult subjects, supporting the recommended dose of 2 mg/m2.
BSA-normalizirani klirens i poluvijek bili su slični bez obzira na dob i u skladu s utvrđenim kod odraslih zdravih ispitanika, što govori u prilog preporučenoj dozi od 2 mg/m2.
BSC = best supportive care, CI = confidence interval, ORR = objective response rate (patients with complete response or partial response), OS = overall survival time, PFS = progression-free survival time
BSC (best supportive care) = najbolja suportivna terapija, CI = interval pouzdanosti, ORR (objective response rate) = stopa objektivnog odgovora (bolesnici s potpunim ili djelomičnim odgovorom), OS (overal survival time)= ukupno vrijeme preživljenja, PFS (progression-free survival time) = vrijeme preživljenja bez napredovanja bolesti
BSC Cetuximab plus BSC
BSC Cetuksimab i BSC
Btk promotes survival of B lymphocytes and their migration to the organs where these cells normally divide.
Btk potiče preživljenje limfocita B i njihovu migraciju do organa, u kojima uobičajeno nastupa dioba ovih stanica.
BTV 2 antigen ...........................................................................................................
BTV2 antigen ..........................................................................................................
BTV 4 antigen ...........................................................................................................
BTV4 antigen ...........................................................................................................
BTV 4 antigen ....................................................................................................................7.1–8.5 CCID50
BTV4 antigen ..................................................................................................................7,1 – 8,5 CCID50
BTV 8 antigen ......................................................................................................  2.1 log10 pixels/dose
BTV 8 antigen ......................................................................................................  2,1 log10 pixels/doza
BTV 8 antigen ……… 106.5 CCID50/ml.
Antigen BTV8 106,5 CCID50/ml
BTV 8 antigen ……… 106.5 CCID50/ml.
BTV 8 antigen ……… 106,5 CCID50/ml
BTV- 1/ALG2006/01 E1 RP* ≥ 1
BTV-1/ALG2006/01 E1